Home / Business and Economy / Weight-Loss Drugs Hit Alcohol Sales Hard
Weight-Loss Drugs Hit Alcohol Sales Hard
9 Oct
Summary
- GLP-1 drugs may impact alcohol consumption more than food.
- Non-alcoholic hemp THC beverages are gaining popularity.
- This new beverage category could reach $50 billion annually.
The burgeoning market of GLP-1 weight-loss drugs is poised to significantly disrupt the alcohol industry, according to Nate Cooper, founder of Barrel Ventures. Cooper asserts that these medications, which are known to decrease addictive behaviors, will likely have a more profound effect on alcohol consumption than on food purchases. He noted that while major food corporations are pushing back against concerns, the impact on snacking may be a "slow drip effect" as brands adjust to people eating less by increasing protein and fiber content.
Cooper highlighted the rise of alternative beverages, citing his fund's investment in Nowadays, a hemp THC drink. This product has already achieved remarkable success, becoming the second-highest selling item at a major liquor retailer, trailing only Tito's vodka. These new beverages offer consumers a similar sensation to drinking alcohol but without the detrimental morning-after effects.
Cooper projects that this novel category could potentially account for 10% of all alcohol sales in stores, translating to an estimated $50 billion annually. He stressed the importance of establishing a regulatory framework for these drinks, suggesting measures such as age-gating, milligram caps, and the elimination of synthetic ingredients to manage their growth and safety.
